|
Market Closed -
Nasdaq
16:00:00 2026-09-29 EDT
|
5-day change | 1st Jan Change | ||
| 15.58 USD | +3.32% |
|
-5.63% | -14.21% |
| 09-20 | Avalo Therapeutics, Inc.(NasdaqCM:AVTX) added to S&P Global BMI Index | CI |
| 08-19 | Avalo Therapeutics Insider Sold Shares Worth $1,450,419, According to a Recent SEC Filing | MT |
Stock exchange
Quotes 5-day view: Avalo Therapeutics, Inc.
Delayed Quote Nasdaq
| 2026-09-23 | 2026-09-24 | 2026-09-25 | 2026-09-28 | 2026-09-29 | |
|---|---|---|---|---|---|
| Last | US$15.30 | US$15.72 | US$15.47 | US$15.08 | US$15.58 |
| Volume | 1,111,198 | 1,897,032 | 1,433,836 | 749,653 | 1,331,568 |
| Change | -7.33% | +2.75% | -1.59% | -2.52% | +3.32% |
| Opening | US$16.40 | US$15.24 | US$15.75 | US$15.47 | US$15.16 |
| High | US$16.49 | US$16.10 | US$15.81 | US$15.47 | US$15.67 |
| Low | US$15.13 | US$14.58 | US$15.00 | US$14.97 | US$14.74 |
Performance
| 1 day | +3.32% | ||
| 1 week | -5.63% | ||
| Current month | -19.44% | ||
| 1 month | -20.47% | ||
| 3 months | -19.23% | ||
| 6 months | +12.17% | ||
| Current year | -14.21% | ||
| 1 year | +19.66% | ||
| 3 years | -46.22% | ||
| 5 years | -99.76% | ||
| 10 years | -99.88% |
Volumes
marketsDaily volume
1,331,568
Estimated daily volume
1,331,568
Avg. Volume 20 sessions
1,243,021
Daily volume ratio
1.07
Avg. Volume 20 sessions USD
19,366,267.18
Record volume 1
31,910,412
Record volume 2
22,460,588
Record volume 3
8,576,599
Capital turnover ratio
0.02
Float rotation
0.02
Basic data
Market Cap (USD)
835,555,228
Net sales (USD)
59,000
Number of employees
33
Sales / Employee (USD)
1,788
Free-Float
98.31%
Free-Float capitalization (USD)
821,446,307
Average Daily Capital Traded
2.32%
Indicators
Moving average 5 days
15.43
Moving average 20 days
17.17
Moving average 50 days
18.4
Moving average 100 days
17.73
Price spread / (MMA5)
-0.96%
Price spread / (MMA20)
+10.21%
Price spread / (MMA50)
+18.09%
Price spread / (MMA100)
+13.77%
STIM
RSI 9 days
28.78
RSI 14 days
32.74
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.32% | -5.63% | +19.66% | -46.22% | 836M | |
| -0.70% | -4.28% | +52.62% | +86.42% | 71.53B | |
| +0.05% | +1.56% | +37.52% | +81.76% | 60.12B | |
| +4.77% | +6.16% | +36.77% | +26.10% | 27.98B | |
| -1.73% | -4.30% | -18.37% | +357.94% | 25.25B | |
| -0.51% | -2.28% | +0.48% | -9.27% | 24.76B | |
| +0.58% | +1.57% | +20.78% | -4.75% | 20.99B | |
| +3.46% | +3.02% | +158.90% | +337.81% | 15.54B | |
| +0.48% | +0.86% | +44.56% | +168.42% | 14.53B | |
| +2.96% | +0.83% | -5.25% | +519.59% | 14.41B | |
| Average | +1.28% | -1.28% | +34.77% | +151.78% | 27.59B | |
| Weighted average by Cap. | +0.54% | -1.53% | +36.57% | +129.31% |
Historical Quotes: Avalo Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
3937588715219322701.0gNwEcx_xtn7sExCxGokz4rUUC_k9oEwVuE22ljssj4.5E4lSLg7gJ-y5AoTlV99vOWNF3XdtfBDJ4BGng-c2XyZcUVglDOlmMjHOw
| Date | Price | Volume | Total |
|---|---|---|---|
| 16:00:00 | 15.58 | 100,949 | 916,807 |
| 15:59:58 | 15.57 | 193 | 815,858 |
| 15:59:58 | 15.57 | 100 | 815,665 |
| 15:59:58 | 15.56 | 100 | 815,565 |
| 15:59:57 | 15.55 | 100 | 815,465 |
| 15:59:57 | 15.56 | 100 | 815,365 |
| 15:59:57 | 15.57 | 100 | 815,265 |
| 15:59:56 | 15.56 | 100 | 815,165 |
| 15:59:56 | 15.55 | 200 | 815,065 |
| 15:59:56 | 15.55 | 140 | 814,865 |
Price Extremes
| 1 week | 14.58 |  | 16.1 |
| 1 month | 14.58 | | 20.49 |
| Current year | 12.51 | | 24.27 |
| 1 year | 12.41 | | 24.27 |
| 3 years | 3.39 | | 45.1 |
| 5 years | 3.39 | | 7,055.95 |
| 10 years | 3.39 | | 22,031.54 |
Monthly variations
Annual variations
| 2026 | -14.21% | ||
| 2025 | +144.41% | ||
| 2024 | -18.35% | ||
| 2023 | -99.25% | ||
| 2022 | -75.29% | ||
| 2021 | -35.61% | ||
| 2020 | -51.02% | ||
| 2019 | +66.87% | ||
| 2018 | +0.94% | ||
| 2017 | +263.47% | ||
| 2016 | -73.72% | ||
| 2015 | -16.25% |
- Stock Market
- Stocks
- AVTX Stock
- Quotes Avalo Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
